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Community-based interventions for the prevention
and control of helmintic neglected tropical
diseases
Rehana A Salam1, Hasina Maredia2, Jai K Das1, Zohra S Lassi1 and Zulfiqar A Bhutta3,4*
Abstract
In this paper, we aim to systematically analyze the effectiveness of community-based interventions (CBIs) for the
prevention and control of helminthiasis including soil-transmitted helminthiasis (STH) (ascariasis, hookworms, and
trichuriasis), lymphatic filariasis, onchocerciasis, dracunculiasis, and schistosomiasis. We systematically reviewed
literature published before May 2013 and included 32 studies in this review. Findings from the meta-analysis
suggest that CBIs are effective in reducing the prevalence of STH (RR: 0.45, 95% CI: 0.38, 0.54), schistosomiasis
(RR: 0.40, 95% CI: 0.33, 0.50), and STH intensity (SMD: −3.16, 95 CI: −4.28, −2.04). They are also effective in improving
mean hemoglobin (SMD: 0.34, 95% CI: 0.20, 0.47) and reducing anemia prevalence (RR: 0.90, 95% CI: 0.85, 0.96).
However, it did not have any impact on ferritin, height, weight, low birth weight (LBW), or stillbirths. School-based
delivery significantly reduced STH (RR: 0.49, 95% CI: 0.39, 0.63) and schistosomiasis prevalence (RR: 0.50, 95% CI: 0.33,
0.75), STH intensity (SMD: −0.22, 95% CI: −0.26, −0.17), and anemia prevalence (RR: 0.87, 95% CI: 0.81, 0.94). It also
improved mean hemoglobin (SMD: 0.24, 95% CI: 0.16, 0.32). We did not find any conclusive evidence from the
quantitative synthesis on the relative effectiveness of integrated and non-integrated delivery strategies due to the
limited data available for each subgroup. However, the qualitative synthesis from the included studies supports
community-based delivery strategies and suggests that integrated prevention and control measures are more
effective in achieving greater coverage compared to the routine vertical delivery, albeit it requires an existing strong
healthcare infrastructure. Current evidence suggests that effective community-based strategies exist and deliver a range
of preventive, promotive, and therapeutic interventions to combat helminthic neglected tropical diseases (NTDs).
However, there is a need to implement and evaluate efficient integrated programs with the existing disease control
programs on a larger scale throughout resource-limited regions especially to reach the unreachable.
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Introduction
Helminths (Greek, meaning ‘worms’) are parasitic worms
that have been harboring in humans throughout the
ages. These are classified as nematodes or round-
worms and include soil-transmitted helminths (ascariasis,
hookworms, and trichuriasis) and filarial (causing
lymphatic filariasis [LF] and onchocerciasis), whereas the
platyhelminthes or flatworms include the flukes (schis-
tosomes) and tapeworms. As discussed in Paper 1 [1],
helminthic infections are a prominent subgroup within
neglected tropical diseases (NTDs), primarily perpetuated
due to a lack of access to safe water and sanitation. The
most common helminths are the soil-transmitted hel-
minthiasis (STH), followed by schistosomiasis and LF.
These are often co-infectious, although the biology of each
disease differs. These infections disproportionately affect
children, pregnant women, and young adults resulting in
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serious chronic health conditions including malnutrition,
physical and intellectual growth retardations in children,
and adverse maternal, perinatal and delivery outcomes
among pregnant women [2-4]. Onchocerciasis is a leading
cause of blindness and skin disease, while LF is a major
cause of limb and genital deformities. For a more tho-
rough discussion on the epidemiology and burden of
each of these diseases, please refer to our previous
publication [1].
Mass drug administration (MDA) with anthelminthics
has been a major approach to combat human helminth-
iasis while parallel interventions such as micronutrient
supplementation, especially iron, to combat associated
anemia has also been widely evaluated for effectiveness
[5]. Sanitation and education are also recommended, how-
ever, these are not always feasible in resource-limited set-
tings. All these strategies can be effectively administered
via community delivery platforms. Child health days,
micronutrient supplementation, vaccination programs,
and school-based programs provide a potential entry point
for periodic deworming and health education in a more
cost-effective manner [6]. In this paper, we aim to system-
atically analyze the effectiveness of community-based
interventions (CBIs) for the prevention and control of
helminthiasis including STH (ascariasis, hookworms,
and trichuriasis), LF, onchocerciasis, dracunculiasis, and
schistosomiasis.
Methods
We systematically reviewed literature published before
May 2013 to identify studies on the effectiveness of the
community-based delivery of interventions highlighted
in our conceptual framework [7] for the outlined hel-
minthic diseases. Our priority was to select existing ran-
domized, quasi-randomized, and before-and-after studies
in which the intervention was delivered within commu-
nity settings and the reported outcomes were relevant to
the diseases under review. A separate search strategy was
developed for each disease using appropriate keywords,
medical subject headings (MeSH), and free text terms.
Searches were conducted in the PubMed, Cochrane Li-
braries, Embase, and the World Health Organization
(WHO) Regional Databases. Studies that met the inclu-
sion criteria were selected and double data was abstracted
on a standardized abstraction sheet. Quality assessment of
the included randomized controlled trials (RCTs) was
done using the Cochrane risk of bias assessment tool [8].
The outcomes of interest assessed for each of the above
diseases are outlined in Table 1. We conducted a meta-
analysis for individual studies using the software Review
Manager 5.1. Pooled statistics were reported as the rela-
tive risk (RR) for categorical variables and standard mean
difference (SMD) for continuous variables between the ex-
perimental and control groups with 95% confidence
intervals (CIs). We also attempted to qualitatively
synthesize the findings reported in the included studies
for other pragmatic parameters identified in our concep-
tual framework including intervention coverage, chal-
lenges/barriers, enabling factors, aspects related to
integrated delivery, monitoring, and evaluations and
equity. The detailed methodology is described in Paper 2
of this series [7].
Review
We identified 2,556 titles from the searches conducted
in all databases. After screening titles and abstracts, 208
full texts were reviewed, of which 32 studies (17 RCTs,
two quasi, and 13 before-and-after studies) were in-
cluded in the review (see Figure 1). The characteristics
of the included studies are summarized in Table 2. Of
these 32 studies, four could not be included in the meta-
analysis; one study [9] did not report any outcome of
interest, poolable data was not available in two studies
[10,11], while one [12] did not have a suitable control
group for comparison. We did not find any quantifiable
data from the studies on dracunculiasis, LF, and oncho-
cerciasis to be included in the pooled analysis. For the
17 RCTs included in this review, randomization was ad-
equate in 15 studies, allocation was concealed in six, and
adequate sequence generation was also done in six. All
studies provided insufficient information on selective
reporting which limited us from making any judgment
(see Table 3).
Included studies mainly focused on community-based
MDA, which involved preventive chemotherapy in 19 of
the studies and treatment after confirmed diagnosis in
11 studies. A school-based delivery strategy was the
Table 1 Outcomes analyzed
Outcomes Outcomes analyzed
Morbidity • Hookworm prevalence and intensity
• Ascaris prevalence and intensity
• Trichuris prevalence and intensity
• Schistosoma haematobium prevalence
• Schistosoma mansoni prevalence
• Schistosoma japonicum prevalence
Anthropometry • Weight
• Height
Hematologic • Prevalence of anemia
• Mean hemoglobin
• Serum ferritin
Birth outcomes • Birth weight
• Low birth weigh
• Very low birth weight
• Stillbirths
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most common delivery strategy used in 12 [9,13-21,24,25]
studies targeting children aged five to 15 years, thirteen
[10,12,22,23,25-32,40] studies were non-integrated verti-
cally delivered interventions, seven [11,33,34,36-39] were
integrated with primary healthcare (PHC), and routine
antenatal care (ANC) services. Almost all the studies had
a component on health education to promote general
hygiene and sanitation along with the drug administration.
Other co-interventions included iron and β-carotene sup-
plementation, snail control, constructing latrines, elimin-
ating cattle from the residential areas, staff training, and
community mobilization. One study [31] assessed the ef-
fectiveness of constructing a water recreation area in the
community using a local lake to prevent transmission of
schistosomiasis among school children. Most of the
studies provided combined drug treatment for the preven-
tion and treatment of hookworms, ascariasis, trichuria-
sis, and schistosomiasis with the treatment regimen
including administration of albendazole (ALB) 400 mg
for STH and praziquantel (PZQ) 40 mg/kg for schis-
tosomiasis, while mebendazole (MBZ) 500 mg was
used in four studies [11,14,27,37] and one study [14]
also administered pyrantel-oxantel (10 mg/kg). The
frequency of treatment varied according to the preva-
lence in the intervention area. We also attempted to con-
duct a subgroup analysis for the relative effectiveness of
preventive and therapeutic drug administration, integrated
and non-integrated delivery strategies, and evidence from
RCTs/quasi and pre-post studies separately, where pos-
sible, and reported the results accordingly. The results are
summarized in Tables 4 and 5.
Quantitative synthesis
Twelve studies reported STH prevalence, showing a sig-
nificant 53% reduction in the overall STH prevalence
(RR: 0.47, 95% CI: 0.41, 0.54) rate, 60% reduction in
hookworm prevalence (RR: 0.40, 95% CI: 0.31, 0.52),
68% in ascariasis (RR: 0.32, 95% CI: 0.20, 0.51), and 34%
(RR: 0.66, 95% CI: 0.55, 0.80) in trichuriasis prevalence
(see Figure 2). Twenty-five studies pooled for schisto-
somiasis prevalence also showed a significant 59% over-
all reduction (RR: 0.41, 95% CI: 0.34, 0.50), with 59%
(RR: 0.41, 95% CI: 0.30, 0.57), 76% (RR: 0.24, 95% CI:
0.07, 0.80) and 52% (RR: 0.48, 95% CI: 0.36, 0.64) reduc-
tions in the prevalence of Schistosoma haematobium,
Schistosoma japonicum, and Schistosoma mansoni, re-
spectively (see Figure 3). CBIs also significantly reduced
the mean STH intensity (SMD: −3.16, 95 CI: −4.28, −2.04).
Twelve studies reported on the hemoglobin (Hb) levels
and showed significantly improved mean Hb in the
intervention group (SMD: 0.34, 95% CI: 0.20, 0.47), while
anemia significantly reduced by 10% (RR: 0.90, 95% CI:
0.85, 0.96) (see Figures 4 and 5). Impacts on serum fer-
ritin, weight, height and delivery outcomes of stillbirth,
low birth weight (LBW), and very LBW remained non-
significant in the overall, as well as the subgroup, analyses.
Our subgroup analysis for the preventive and thera-
peutic drug administration showed that preventive drug
administration significantly reduced the overall prevalence
of STH (RR: 0.43, 95% CI: 0.31, 0.59), STH intensity
(SMD: −0.22, 95% CI: −0.26, −0.17), and schistosomiasis
prevalence (RR: 0.39, 95% CI: 0.27, 0.55), with non-
significant impacts on ascariasis, trichuriasis, and Schis-
tosoma haematobium prevalence. It also significantly
improved mean Hb (SMD: 0.19, 95% CI: 0.12, 0.26) and
reduced anemia prevalence (RR: 0.90, 95% CI: 0.85, 0.96)
and VLBW (RR: 0.38, 95% CI: 0.16, 0.87). Preventive
chemotherapy did not have a significant impact on serum
ferritin, height, weight, LBW, or stillbirths. Therapeutic
drug administration showed significant reductions in
2556 papers ident d
545 abstracts reviewed












Figure 1 Search flow diagram.
Salam et al. Infectious Diseases of Poverty 2014, 3:23 Page 3 of 17
http://www.idpjournal.com/content/3/1/23
Table 2 Characteristics of the included studies
Study Study design Country Intervention Target population Integrated/Non-Integrated
Adam 1995 [13] RCT Kenya Three doses of 400 mg ALB vs. identical placebo
on three consecutive school days
Children aged 5–10 years infected with
hookworms or ascariasis
School-based
Ageel 1997 [33] Pre/post Saudi Arabia One oral dose of PZQ (40 mg/kg) + snail/vector
control + health education + community
participation
General population infected with
schistosomiasis
PHC
Albonico 2002 [14] RCT Tanzania MBZ 500 mg vs. pyrantel-oxantel (10 mg/kg) vs.
placebo
Children aged 6–9 years School-based
Bausch 1995 [35] Quasi Cameroon Health education + PZQ Children aged 5–15 years with
schistosomiasis
PHC + school-based
Beasely 1999 [25] RCT Tanzania Single dose of 400 mg ALB + PPZQ (40 mg/kg)
vs. placebo
Infected children aged 7–12 years Non-integrated
Bhargawa 2003 [15] RCT Tanzania ALB 400 mg + PZQ single 40 mg/kg vs. placebo Infected children aged 9–15 years School-based
Christian 2009 [36] RCT Nepal ALB 40 mg in 2nd + 3rd trimester Pregnant women Integrated with routine ANC
Dossa 2001 [26] RCT Benin Iron (Fe) (60 mg/day) + ALB (200 mg for 3 days)
vs. FE + placebo vs. ALB + placebo vs. placebo
10 months F/V
Children aged 3–5 years Non-integrated
Engels 1993 [11] Pre/post Burundi Single dose PZQ (40 mg/kg), 50–150 mg
levamisole or 500 mg MBL or PZQ (20 mg/kg) +
snail vector control + education
General population PHC
Gryseels 1991 [23] Pre/post Burundi PZQ (40 mg/kg) General population Non-integrated
Gundersen 1990 [34] Pre/post Ethiopia Vector snail control + 20 mg oxamniquine
followed by 40 mg the next day
General population PHC
Guyatt 2001 [16] Pre/post Tanzania Single dose 400 mg ALB + PZQ 40 mg/kg School children aged 8–14 years School-based
Halwindi 2011 [27] RCT Zambia Facility vs. community detected and treatment +
training + education +MBZ
Children aged 12–months (preventive) Non-integrated
Haque 2010 [28] RCT Bangladesh 400 mg ALB + B-carotene (2 doses) vs. ALB +
placebo vs. B-carotene + placebo vs. placebo +
placebo
Infected children aged 24–60 months Non-integrated
Hathirat 1992 [24] RCT Thailand Fe 50 mg FeSo 4 daily for 2 weeks then 100 mg
for 14wks vs. anthelminthic
Children aged 9–11 years School-based
Kosinski 2012 [31] Pre/post Ghana Water recreation area + PZQ Children Non-integrated
Koukounari 2006 [17] Pre/post Uganda PZQ Children aged 7–14 years School-based
Koukounari 2007 [18] Pre/post Burkina Faso PZQ 40 mg/kg + ALB 400 mg Children aged 6–14 years School-based
Larocque 2006 [37] RCT Peru MBZ 500 mg single dose + 60 mg FE daily vs.
placebo + FE
Pregant women aged 18–44 years in the
2nd trimester
Integrated with routine ANC
Ndibazza 2010 [38] RCT Uganda ALB (400 mg) vs. PZQ 40 mg/kg vs. ALB + PZQ
vs. placebo


















Table 2 Characteristics of the included studies (Continued)
Nsowah-Nuamah 2001 [12] Pre/post Ghana PZQ 40 mg/kg + passive edu vs. PZQ + no
education vs. PZQ + active edu vs. community
mobilization
Those aged 5 years and above Non-integrated
Olds 1999 [29] RCT China and Philippines ALB + PZQ vs. PZQ + ALB placebo vs. ALB + PZQ
placebo vs. placebo + placebo
Infected school aged children (4–18 years) Non-integrated
Palupi 1997 [30] RCT Indonesia FE + ALB 400 mg once a week vs. FE once a
week + placebo vs. placebo alone
Children aged 2–5 years Non-integrated
Phuc 2009 [40] Pre/post Vietnam IEC materials + staff training + Ferrous Sulphate/
folic acid (200 mg) + ALB (400 mg)
Women of reproductive age (16–45 years) Non-integrated
Rohner 2010 [19] RCT Cote d’Ivoire Iron fortified biscuits (20 mg fe/day) + IPT-SP
(500 mg sulphadoxine + 25 mg pyrimethamine) +
anthelminthic (400 mg-single) + PZQ (single –
40 mg/kg) in different combinations
School children aged 6–14 years School-based
Savioli 1989 [9] Pre/post Tanzania PZQ Children School-based
Sungthong 2002 [20] RCT Thailand Deworming (400 mg ALB single) + daily or
weekly iron
Children aged 6–13 years School-based
Sinoun 2007 [10] Pre/post Cambodia Universal chemotherapy with PZQ (40 mg/kg) General population Non-integrated
Taylor 2001 [21] RCT South Africa ALB (400 mg) + PZQ (40 mg/kg) + FE fumigate
200 mg weekly vs. ALB (400 mg) + PZQ (40 mg/
kg) + placebo weekly vs. ALB (400 mg) daily +
PZQ (40 mg/kg) + FE 200 mg weekly vs. ALB
(400 mg) + PZQ (40 mg/kg) + placebo weekly vs.
placebos + FE 200 mg weekly vs. placebos
Children aged 6–15 years School-based
Torlesse 2001 [39] RCT Sierra Leone FE + ALB vs. FE alone vs. ALB alone vs. placebo Pregnant women (10–14 weeks) Integrated with routine ANC
Wang 2009 [32] Quasi China Health education + vector control + removing
cattle + latrines + PZQ
General population Non-integrated


















STH prevalence (RR: 0.52, 95% CI: 0.44, 0.61), inten-
sity (SMD: −5.29, 95% CI: −9.22, −1.36), and schistosomia-
sis prevalence (RR: 0.41, 95% CI: 0.30, 0.55). Our analysis
did not show a significant impact of therapeutic chemo-
therapy on serum ferritin, Hb, weight, or height.
Findings from the subgroup analysis for school-based,
non-integrated, and integrated delivery strategies suggest
that school-based delivery significantly reduced STH
prevalence (RR: 0.49, 95% CI: 0.39, 0.63) and intensity
(SMD: −0.22, 95% CI: −0.26, −0.17), and the prevalence
of all types of schistosomiasis (RR: 0.50, 95% CI: 0.33,
0.75), with a non-significant impact on Schistosoma
mansoni. It also improved mean Hb (SMD: 0.24, 95% CI:
0.16, 0.32) and reduced anemia prevalence (RR: 0.87,
95% CI: 0.81-0.94) among school children. However,
school-based delivery did not show any significant im-
pact on serum ferritin, height, and weight. Non-
integrated delivery reduced STH prevalence (RR: 0.52,
95% CI: 0.41, 0.67), intensity (SMD: −5.29, 95% CI: −
9.22, −1.36), and schistosomiasis prevalence (RR: 0.42,
95% CI: 0.31, 0.57), with a non-significant impact
on Schistosoma mansoni. Integrated delivery improved
schistosomiasis prevalence (RR: 0.24, 95% CI: 0.11, 0.5)
and overall STH prevalence (RR: 0.30, 95% CI: 0.12,
0.78), with non-significant impacts on the prevalence of
hookworm or trichuriasis.
Qualitative synthesis
Since most of the quantitative outcomes reported per-
tained to disease specific indicators, we also attempted
to qualitatively synthesize the findings reported in the
included studies on other pragmatic parameters from
our conceptual framework. CBIs have been reported
to achieve large-scale nationwide coverage as seen in
Burkina Faso, which was the first country in the WHO
African Region to achieve nationwide coverage with
anthelminthic drugs against three major NTDs: LF, schis-
tosomiasis, and STH [18]. Furthermore, when delivered in
integration with the existing health systems, these pro-
grams can achieve maximum coverage as seen in the
Gizan region, where a vertically-oriented program, involv-
ing mobile teams for schistosome control, failed to achieve
the target of 80% population coverage and was costly to
sustain. The same program, when later on integrated with
the existing PHC, led to a significant increase in the num-
bers of patients examined and chemotherapy coverage.
Similarly in Zimbabwe and Burundi, schistosomiasis and
other control programs for NTDs have increasingly been
integrated into horizontal PHC systems [23]. The available
health infrastructure allows the control strategy to be very
well integrated into basic health services, enabling it to be
sustained and making it affordable for the national health
budget [11]. In a health system that generally enjoys a
strong structure from the provincial level down to the
community level, successful integration of these services
are relatively easier and just require making small modifi-
cations to the existing system. However, this process may
require more attention in countries where the health ser-
vice structure is weak. The PHC approach has led to bet-
ter coverage as compared to the vertical programs, and
Table 3 Quality assessment of the included RCTs








Larocque 2006 [37] Done Done Done Done Done No
Ndibazza 2010 [38] Done Done Done Done Done No
Torlesse 2001 [39] Done Done Not clear Not clear Not clear Yes
Haque 2010 [28] Done Not clear Not clear Done Not clear No
Albonico 2002 [14] Done Done Done Done Done No
Taylor 2001 [21] Done Not clear Not clear Done Done Not clear
Adams 1994 [13] Done Not clear Not clear Done Not clear No
Beasley 1999 [25] Done Not computerized but done Not clear Not done Done No
Christian 2009 [36] Not clear Not clear Not clear Not Clear Not Clear Not clear
Halwindi 2011 [27] Not clear Not clear Not applicable Not applicable Not clear No
Olds 1999 [29] Done Not clear Done Done Done Not clear
Rohner 2010 [19] Done Not clear Done Done Done No
Bhargava 2003 [15] Done Not clear Not clear Not clear Not clear No
Palupi 1997 [30] Done Not clear Not clear Not clear Not clear No
Dossa 2001 [26] Done Not clear Not clear Done Done Yes
Hathirat 1992 [24] Done Not clear Not clear Done Done No
Sungthong 2002 [20] Done Done Done Done Done No
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Table 4 Results for the overall and subgroup analysis according to type of study and treatment
Outcomes Estimates (95% CI)
Combined RCTs Pre-post studies Preventive Therapeutic
STH Prevalence (RR) 0.47 [0.41, 0.54] 0.47 [0.41, 0.55] 0.51 [0.40, 0.65] 0.43 [0.31, 0.59] 0.52 [0.44, 0.61]
45 datasets from 12 studies 40 datasets from 9 studies 5 datasets from 3 studies 22 datasets from 7 studies 23 datasets from 5 studies
Hookworm 0.40 [0.31, 0.52] 0.41 [0.32, 0.54] 0.39 [0.23, 0.65] 0.26 [0.14, 0.45] 0.60 [0.46, 0.78]
15 datasets, 10 studies 13 datasets from 8 studies 2 datasets from 2 studies 8 datasets from 6 studies 7 datasets from 4 studies
Ascariasis 0.32 [0.20, 0.51] 0.30 [0.18, 0.49] 0.61 [0.41, 0.90] 0.62 [0.38, 1.01] 0.18 [0.08, 0.40]
15 datasets, 9 studies 14 datasets from 8 studies 1 dataset from 1 study 7 datasets from 4 studies 8 datasets from 5 studies
Trichuriasis 0.66 [0.55, 0.80] 0.65 [0.53, 0.79] 0.97 [0.68, 1.37] 0.57 [0.22, 1.46] 0.76 [0.66, 0.88]
14 datasets, 8 studies 13 datasets from 7 studies 1 dataset from 1 study 6 datasets from 3 studies 8 datasets from 5 studies
Schistosomiasis Prevalence (RR) 0.41 [0.34, 0.50] 0.42 [0.33, 0.54] 0.37 [0.25, 0.55] 0.39 [0.27, 0.55] 0.41 [0.30, 0.55]
25 datasets, 13 studies 16 datasets from 6 studies 9 datasets from 7 studies 11 datasets from 7studies 14 datasets from 6 studies
Schistosoma Haematobium 0.41 [0.30, 0.57] 0.43 [0.29, 0.64] 0.33 [0.17, 0.65] 0.59 [0.35, 1.02] 0.31 [0.18, 0.52]
10 datasets, 8 studies 6 datasets from 4 studies 4 datasets from 4 studies 3 datasets from 3 studies 7 datasets from 5 studies
Schistosoma Japonicum 0.24 [0.07, 0.80] 0.24 [0.07, 0.80] No studies 0.11 [0.05, 0.26] 0.30 [0.07, 1.31]
4 datasets, 2 studies 4 datasets from 2 studies 1 dataset from 1 study 3 datasets from 1 study
Schistosoma Mansoni 0.48 [0.36, 0.64] 0.55 [0.38, 0.81] 0.39 [0.25, 0.62] 0.37 [0.24, 0.58] 0.67 [0.45, 1.01]
11 datasets, 7 studies 6 datasets from 2 studies 5 datasets from 5 studies 7 datasets from 5 studies 4 datasets from 2 studies
STH intensity (SMD) −3.16 [−4.28, −2.04] −5.29 [−9.22, −1.36] −0.22 [−0.26, −0.17] −0.22 [−0.26, −0.17] −5.29 [−9.22, −1.36]
5 datasets, 3 studies 3 datasets from 1 study 2 datasets from 2 studies 2 datasets from 2 studies 3 datasets from 1 study
Hookworm −2.22 [−3.27, −1.17] −6.79 [−7.44, −6.14] −0.22 [−0.26, −0.17] −0.22 [−0.26, −0.17] −6.79 [−7.44, −6.14]
3 datasets, 03 studies 1 dataset from 1 study 2 datasets from 2 studies 2 datasets from 2 studies 1 dataset from 1 study
Ascariasis −7.25 [−7.93, −6.56] −7.25 [−7.93, −6.56] No studies No studies −7.25 [−7.93, −6.56]
1 dataset, 1 study 1 dataset from 1 study 1 dataset from 1 study
Trichuriasis −1.87 [−2.16, −1.57] −1.87 [−2.16, −1.57] No Studies No studies −1.87 [−2.16, −1.57]
1 dataset, 01 study 1 dataset from 1 study 1 dataset from 1 study
Mean hemoglobin (SMD) 0.34 [0.20, 0.47] 0.43 [0.15, 0.71] 0.22 [0.13, 0.31] 0.19 [0.12, 0.26] 1.28 [−0.53, 3.08]
14 datasets, 12 studies 9 datasets from 7 studies 5 datasets from 5 studies 12 datasets from 10 studies 2 datasets from 2 studies
Anemia 0.90 [0.85, 0.96] 0.92 [0.85, 1.00] 0.87 [0.78, 0.97] 0.90 [0.85, 0.96] 0.85 [0.69, 1.06]
9 datasets, 7 studies 5 datasets from 3 studies 4 datasets from 4 studies 8 datasets from 6 studies 1 dataset from 1 study
Serum ferritin (SMD) 2.30 [−1.13, 5.73] 0.06 [−0.07, 0.18] 0.10 [−0.16, 0.37] 0.09 [−0.12, 0.29] 0.07 [−0.07, 0.20]
4 datasets, 4 studies 2 dataset from 2 studies 2 datasets from 2 studies 3 datasets from 3 studies 1 dataset from 1 study
Height 0.01 [−0.10, 0.12] −0.04 [−0.16, 0.08] 0.23 [−0.02, 0.49] 0.08 [−0.12, 0.28] −0.02 [−0.15, 0.11]


















Table 4 Results for the overall and subgroup analysis according to type of study and treatment (Continued)
Weight −0.13 [−0.42, 0.16] −0.28 [−0.66, 0.11] 0.22 [−0.03, 0.47] −0.01 [−0.48, 0.46] −0.35 [−1.13, 0.42]
4 datasets, 4 studies 3 datasets from 3 studies 1 dataset from 1 study 2 datasets from 2 studies 2 data sets from 2 studies
Birth outcomes
Birth weight −9.52 [−13.86, −5.19] −9.52 [−13.86, −5.19] No studies −9.52 [−13.86, −5.19] No study
6 datasets, 3 studies 6 datasets from 3 studies 6 datasets from 3 studies
LBW 0.96 [0.78, 1.18] 0.96 [0.78, 1.18] No studies 0.96 [0.78, 1.18] No studies
4 datasets, 2 studies 4 datasets from 2 studies 4 datasets from 2 studies
VLBW 0.48 [0.19, 1.19] 0.48 [0.19, 1.19] No studies 0.48 [0.19, 1.19] No studies
4 datasets, 2 studies 4 datasets, 2 studies 4 datasets, 2 studies
Stillbirths 1.54 [0.93, 2.58] 1.54 [0.93, 2.58] No studies 1.54 [0.93, 2.58] No studies
3 datasets, 1 study 3 datasets from 1 study 3 datasets from 1 study


















Table 5 Summary estimates for the overall and subgroup analysis for school-based, non-integrated, and integrated delivery strategies
Outcomes Estimates (95% CI)
Combined School-based delivery Community-based non-integrated delivery Community-based integrated delivery
STH Prevalence (RR) 0.45 [0.38, 0.54] 0.49 [0.39, 0.63] 0.52 [0.41, 0.67] 0.30 [0.12, 0.78]
45 datasets, 12 studies 19 datasets from 6 studies 16 datasets from 4 studies 9 datasets from 1 study
Hookworm 0.38 [0.27, 0.53] 0.37 [0.22, 0.62] 0.49 [0.29, 0.85] 0.25 [0.04, 1.62]
15 datasets, 10 studies 7 datasets from 5 studies 5 datasets from 3 studies 3 datasets from 1 study
Ascariasis 0.32 [0.19, 0.52] 0.28 [0.09, 0.89] 0.36 [0.18, 0.74] 0.28 [0.09, 0.87]
15 datasets, 9 studies 4 datasets from 6 studies 6 datasets from 4 studies 3 datasets from 1 studies
Trichuriasis 0.66 [0.53, 0.82] 0.78 [0.67, 0.90] 0.76 [0.62, 0.94] 0.41 [0.07, 2.56]
14 datasets, 8 studies 4 datasets from 6 studies 5 datasets from 3 study 3 datasets from 1 studies
Schistosomiasis Prevalence (RR) 0.40 [0.33, 0.50] 0.50 [0.33, 0.75] 0.42 [0.31, 0.57] 0.24 [0.11, 0.56]
25 datasets, 13 studies 7 datasets from 5 studies 12 datasets from 4 studies 6 datasets from 4 studies
S. Haematobium 0.40 [0.29, 0.57] 0.59 [0.35, 1.02] 0.42 [0.26, 0.70] 0.05 [0.01, 0.45]
10 datasets, 8 studies 3 datasets from 3 studies 5 datasets from 3 studies 2 datasets from 2 studies
S. Japonicum 0.24 [0.06, 0.87] No studies 0.24 [0.06, 0.87] No studies
4 datasets, 2 studies 4 datasets from 2 studies
S. Mansoni 0.48 [0.35, 0.65] 0.44 [0.27, 0.74] 0.68 [0.42, 1.10] 0.38 [0.16, 0.91]
11 datasets, 7 studies 4 datasets from 4 studies 3 datasets from 1 study 4 datasets from 2 studies
STH intensity (SMD) −3.16 [−4.28, −2.04] −0.22 [−0.26, −0.17] −5.29 [−9.22, −1.36] No studies
5 datasets, 3 studies 2 datasets, 2 studies 3 datasets from 1 study
Hookworm −2.22 [−3.27, −1.17] −0.22 [−0.26, −0.17] −6.79 [−7.44, −6.14] No studies
3 datasets, 3 studies 2 datasets, 2 studies 1 dataset from 1 study
Ascariasis −7.25 [−7.93, −6.56] No studies −7.25 [−7.93, −6.56] No studies
1 dataset, 1 study 1 dataset from 1 study
Trichuriasis −1.87 [−2.16, −1.57] No studies −1.87 [−2.16, −1.57] No studies
1 dataset, 1 study 1 dataset from 1 study
Mean hemoglobin (SMD) 0.34 [0.20, 0.47] 0.24 [0.16, 0.32] 0.93 [−0.33, 2.18] 0.09 [−0.01, 0.20]
14 datasets, 12 studies 7 datasets from 7 studies 3 datasets from 3 studies 4 datasets from 2 studies
Anemia 0.90 [0.85, 0.96] 0.87 [0.81, 0.94] 0.85 [0.69, 1.06] 0.99 [0.90, 1.09]
9 datasets, 7 studies 5 datasets from 5 studies 1 datasets from 1 study 3 datasets from 1 study
Serum ferritin (SMD) 2.30 [−1.13, 5.73] 0.10 [−0.04, 0.25] No studies −0.01 [−0.36, 0.34]
4 datasets, 4 studies 3 datasets from 3 studies 1 dataset from 1 study
Height 0.01 [−0.10, 0.12] 0.04 [−0.08, 0.15] −0.19 [−0.53, 0.14] No studies


















Table 5 Summary estimates for the overall and subgroup analysis for school-based, non-integrated, and integrated delivery strategies (Continued)
Weight −0.13 [−0.42, 0.16] −0.09 [−0.46, 0.27] −0.27 [−0.60, 0.07] No studies
4 datasets, 4 studies 3 datasets from 3 studies 1 dataset from 1 study
Birth outcomes
Birth weight −9.52 [−13.86, −5.19] No studies No studies −9.52 [−13.86, −5.19]
6 datasets, 3 studies 6 datasets from 3 studies
LBW 0.96 [0.78, 1.18] No studies No studies 0.96 [0.78, 1.18]
4 datasets, 2 studies 4 datasets from 2 studies
VLBW 0.38 [0.16, 0.87] No studies No studies 0.38 [0.16, 0.87]
4 datasets, 2 studies 4 datasets from 2 studies
Stillbirths 1.54 [0.93, 2.58] No studies No studies 1.54 [0.93, 2.58]
3 datasets, 1 study 3 datasets from 1 study


















Figure 2 Forest plot for the impact of CBIs on STH prevalence.
Salam et al. Infectious Diseases of Poverty 2014, 3:23 Page 11 of 17
http://www.idpjournal.com/content/3/1/23
has been effective in reducing the overall prevalence of
helminthic infections.
CBIs have achieved a higher coverage without any in-
crease in implementation costs at the district and health
facility levels. At the community level, there is an in-
crease in ‘opportunity costs’ from community implemen-
ters who volunteer their time, thus forgoing other
remunerative activities. Some of the studies reported no
major direct additional costs incurred because the drugs,
training materials, and stationary were provided by the
PHC from their available resources, and the community
health workers (CHWs) were not given any monetary in-
centives. Hence, the major additional costs included the
indirect cost of labour hours for the CHWs and the
PHC staff during training and implementation of the
program. However, for national scale-up, the biggest
Figure 3 Forest plot for the impact of CBIs on schistosomiasis.
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challenge is likely to be the cost of training and incen-
tives for the CHWs [27]. Similarly, school-based de-
livery of preventive and promotive interventions is also
reported to be cost effective, however, its success de-
pended on close supervision of the teachers’ compliance
with the program implementation, collaboration of the
educational authorities, and enthusiastic participation of
the school personnel [24]. On the contrary, in some en-
demic areas, an integrated delivery strategy has not been
successful in improving coverage because of the poor ac-
cess to health services in remote areas. In view of the
strong commitment of national health authorities and
funding agencies to increase PHC coverage, rapid im-
provement of this situation can be expected. For sustained
Figure 4 Forest plot for the impact of CBIs on hemoglobin.
Figure 5 Forest plot for the impact of CBIs on anemia.
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reduction in infection prevalence and complete eradica-
tion, periodic implementation is also necessary to ensure
continuity of morbidity control and achieve universal
coverage. In endemic areas, an intermittent intervention
delivery has shown to reduce the prevalence but did not
completely eradicate the infections. This might be attrib-
utable to the fact that chemotherapy reduces disease
prevalence only at the time of its administration and does
not prevent reinfection [32]. Hence, in endemic areas,
periodic implementation along with efforts to prevent re-
infection is required.
Most of the studies support a multi-component strat-
egy involving chemotherapy, health education, improved
water supply and sanitation, and snail control. Health
education and community involvement have been high-
lighted as essential components in any strategy for hel-
minthic infection control and have been used in many
countries [12,22,33]. Examples of such successful pro-
grams are the chemotherapy program in Sudan where
village health committees served as facilitators, and in
Zimbabwe where CHWs were involved in the imple-
mentation of improvements to the water supply, sani-
tation, and in health education programs. Similarly in
Ethiopia and Egypt, local health personnel, farmers,
school health visitors, and teachers assisted in the imple-
mentation of successful control programs. Knowledge
and education plays an important role as, apparently,
the information motivates the participants and conse-
quently ensures a higher level of compliance [30,40].
The process of designing the program, from its very ini-
tiation, should include open discussions and involvement
of all partners from the international to the local level.
This will ensure that everyone understands the goals,
benefits and underlying principles of the project, and
have the flexibility needed to adapt to particular local
conditions in order to achieve these goals [40]. Strong
commitment of all partners to the intervention has re-
portedly led to excellent participation levels and a sig-
nificant clinical impact [34,40]. Besides health education
and community participation, the socioeconomic devel-
opment leading to a general rise in living standards, im-
proved sanitation and water supplies, construction of
drilled wells in rural areas, and a significant increase in
medical care also played a large part in the control of
helminthic NTDs [33]. Another important enabling fac-
tor was free distribution of drugs and supplies to ensure
equitable distribution to poor and marginalized groups,
which also helped avoid a complicated system of cost re-
covery and achieve high compliance levels.
Financial, logistical, and organizational limitations
were the major reported constraints in the long-term
sustainability of such programs. Despite considerable ef-
forts and their high costs, the results of some of the vec-
tor control programs have been disappointing, largely
because of poor weed control, lack of maintenance, and
the operational difficulty of covering entire networks,
which leads to rapid recolonization of treated sites.
Large-scale health education programs will not serve
their purpose if alternatives to traditional water contact
activities are not available. Maintenance is still reported
as a major hindrance and local authorities should try to
find adequate solutions. Annual tax payments, private la-
trine programs, subsidized prices, and credit facilities are
some of the counter strategies devised to overcome
these issues and ensure sustainability of such programs
after withdrawal of external funds [11]. Another major
challenge is to maintain a high level of participation and
enthusiasm as the project is integrated into the routine
provincial health program [40]. Although maximum
coverage has been achieved in the school-based pro-
grams, frequent migration of people (particularly from
the fishing communities), influx from neighboring coun-
tries, and absence from school of some school-aged chil-
dren remain to be significant hurdles to the successful
implementation of the program [23]. Although often dis-
regarded, religious, economic, and educational hetero-
geneity within communities may also impair disease
control efforts and, hence, these subtle demographic var-
iables must be taken into account.
Discussion
The evidence in this review comes from efficacy and
effectiveness studies on CBIs for helminthic NTDs
compared to routine facility-based care or no interven-
tion. Our review findings suggest that CBIs are effective
in reducing the prevalence of STH and schistosomiasis,
and STH intensity. They are also effective in improving
mean Hb and reducing anemia prevalence, but there
was non-significant impact on serum ferritin, height and
weight gain, LBW, and stillbirths. School-based delivery
was identified as a potential medium of delivery as it sig-
nificantly reduced STH and schistosomiasis prevalence,
STH intensity, and anemia prevalence, however, there
was limited data available on the effectiveness of the
integrated and non-integrated delivery strategies. The
qualitative synthesis from the included studies supports
community-based delivery strategies and suggests that
integrated infection prevention and control measures are
more effective in achieving greater coverage compared
to the routine vertical delivery, albeit it requires an exist-
ing strong healthcare infrastructure. Systematic reviews
have been conducted on helminthic NTDs previously,
however, their scopes were either limited to a particu-
lar infection, drug efficacy or intervention, or the re-
view did not evaluate the effectiveness of community
delivery strategies [41-45].
The WHO recommends periodic administration of an-
thelminthic medicines, mainly ALB and MBZ for STH,
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PZQ for schistosomiasis, and ivermectin or diethylcar-
bamazine citrate (DEC) for LF once or twice a year de-
pending on the baseline prevalence of the infection to
control morbidity among the population at risk [46].
Health education is an essential component in the pre-
vention and control of helminthiasis. Almost all the
studies in this review had a health education component
focusing on general hygiene and sanitation along with
the recommended drug administration. We did not find
any quantifiable data from studies on dracunculiasis, LF,
and onchocerciasis to be included in the pooled analysis.
Among these diseases, much progress has been made
for dracunculiasis and a significant reduction in dracun-
culiasis prevalence of more than 99% has been achieved
since 1989 [47]. Dracunculiasis is successfully at the
verge of eradication due to a combination of interven-
tions including community-based surveillance systems,
intensified case-containment measures, and access to
safe drinking water. Globally, 1.39 billion people still re-
quire preventive chemotherapy for LF while 123 million
people are at risk of becoming infected with onchocer-
ciasis [46,48]. Programs targeting LF and onchocerciasis
are in place in endemic countries, for example, the Global
Programme to Eliminate LF and the African Programme
for Onchocerciasis. These programs enable resource-
limited countries to make medicines freely available and
allow easy access to healthcare with a consequent reduc-
tion in infection prevalence [49].
Community delivery platforms are increasingly being
advocated for the prevention and control of major health
issues such as nutrition and childhood infection, and
hence could be feasible for helminthic NTDs [50,51].
Under these community platforms, integration of vari-
ous disease specific programs is being encouraged for
onchocerciasis, LF, schistosomiasis, STH, and trachoma
[52,53]. The integrated delivery of interventions to con-
trol these diseases is more feasible and cost effective as
these diseases are endemic in specific geographical poc-
kets where population are mostly co-infected and con-
trol mainly involves regular MDA of effective preventive
chemotherapy. Therefore, a package of drugs for more
than one NTD can be feasibly delivered. Critical factors
for successful integration include active support of rele-
vant political and health authorities, a clear understand-
ing by all parties of the health issues, and a simple
distribution process. However, there is limited data avail-
able to gauge the effectiveness of integrated delivery of
these programs along with other health programs
including routine ANC and PHC setups [54,55]. School-
based delivery has proven to be effective for the manage-
ment and control of helminthic diseases as it requires a
minimum amount of training for school teachers to aid
implementation and hence doesn’t require an added work-
force, whilst providing vast coverage at low costs [56].
Conclusion
Current evidence emphasizes that effective community-
based strategies exist and deliver a range of preventive,
promotive, and therapeutic interventions to combat hel-
minthic NTDs. However, there is a need to conduct
high-quality studies on the process of developing and
implementing an efficient integrated program as previ-
ous global programs have focused on the control of a
single NTD through a comprehensive approach. These
interventions exist within the current health systems in
most of the low- and middle-income countries, but there
is a need to implement them on a larger scale especially
to reach the unreachable.
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